Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24weeks
Just $1.99 per week for the first 24weeks
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24weeks

var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);

Today (Dec. 1) marks the 25th World AIDS Day. Two days later, the Global Fund to Fight AIDS, Tuberculosis and Malaria will convene leaders from around the world in Washington to make critical funding pledges to alter the trajectory of these three epidemics. Several governments including the United States, Britain, France, Germany and the Nordic Countries have already announced their pledges. Canada, however, has yet to make an up-front commitment.

We've come a long way in our collective battle with HIV/AIDS. Today, we have the experience and scientific evidence to fight the epidemic effectively. In 2013, UNAIDS reported that the scale-up of treatment has enabled nearly 10 million people to gain access to life-saving medicines. This has been in large part due to the efforts of the Global Fund. In the last decade, the Fund has been a driving force in enabling millions to benefit from prevention, care and treatment programs in their countries.

The Global Fund is the primary mechanism for financing essential HIV medicines in low-income countries. And with more than two-thirds of those living with HIV in sub-Saharan Africa, the Global Fund is the channel through which these drugs reach the most vulnerable people. The Fund enables Dignitas International's medical work in Malawi: one of the poorest countries with one of the highest HIV prevalence rates in the world. In Malawi, Dignitas works to improve patient health through access to quality HIV treatment and care. Since 2004, we've been able to support life-saving treatment for more than 200,000 people and dramatically improve access to HIV services for millions of Malawians. Without a replenished Global Fund, this essential work would simply not be possible.

Story continues below advertisement

Unfortunately, there is a noticeable and disconcerting donor fatigue setting in. However, it is much too soon to let up on our efforts to overcome HIV/AIDS. Last year alone, 2.3 million people were newly infected with HIV – of these people, 260,000 were children. With the advancements in treatment and care, this is simply unconscionable.

The Global Fund needs to raise $15-billion in funding for 2014-16. A full replenishment would result in averting more than 1 million new HIV infections annually through rapid scale-up of treatment. The U.K.'s pledge of $1.5-billion to the Global Fund comes with an important caveat – that the overall $15-billion goal is achieved. This 'strings attached' pledge is intended to encourage other G20 donor countries like Canada to do their part in the global fight against AIDS, Tuberculosis and Malaria.

Along with civil society groups, Dignitas International is asking the Canadian government to make a commitment of at least $750-million over three years. This represents a relatively modest 5 per cent of the total replenishment. An increased Canadian commitment to the Global Fund would save hundreds of thousands of lives and enable us to collectively turn the corner on HIV/AIDS and related diseases.

Why is Canada waiting to announce its commitment? If a strong replenishment is forthcoming, Canada is in a position to play a leadership role and send a clear message to other countries that have yet to come to the table. As Canada seemingly waits for an opportune moment, millions of lives hang in the balance - 18 million to be exact.

This is the number of people who are eligible for HIV treatment but don't have access to medicines. As Canadians, the right to health is integral to our national identity and pride. We now have the chance to tangibly help people in developing countries gain access to life-saving treatment. More than an opportunity, it is a moral obligation.

If there were ever an auspicious moment for Prime Minister Stephen Harper to show Canada's leadership in fighting AIDS, Tuberculosis and Malaria, this would be it.

Now is the moment.

Story continues below advertisement

Dr. James Orbinski is a professor and Global Health Research Chair at the Balsillie School of International Affairs, Laurier University. Dr. Orbinski is also co-founder of Dignitas International; Marilyn McHarg is president and CEO of Dignitas International.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies